Skip to Content
Merck
  • E2F1 interacts with BCL-xL and regulates its subcellular localization dynamics to trigger cell death.

E2F1 interacts with BCL-xL and regulates its subcellular localization dynamics to trigger cell death.

EMBO reports (2017-12-14)
Céline Vuillier, Steven Lohard, Aurélie Fétiveau, Jennifer Allègre, Cémile Kayaci, Louise E King, Frédérique Braun, Sophie Barillé-Nion, Fabien Gautier, Laurence Dubrez, Andrew P Gilmore, Philippe P Juin, Laurent Maillet
ABSTRACT

E2F1 is the main pro-apoptotic effector of the pRB-regulated tumor suppressor pathway by promoting the transcription of various pro-apoptotic proteins. We report here that E2F1 partly localizes to mitochondria, where it favors mitochondrial outer membrane permeabilization. E2F1 interacts with BCL-xL independently from its BH3 binding interface and induces a stabilization of BCL-xL at mitochondrial membranes. This prevents efficient control of BCL-xL over its binding partners, in particular over BAK resulting in the induction of cell death. We thus identify a new, non-BH3-binding regulator of BCL-xL localization dynamics that influences its anti-apoptotic activity.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
Anti-Bim Antibody, internal epitope, pan-Bim isoforms, Chemicon®, from rabbit
Sigma-Aldrich
Anti-Actin Antibody, clone C4, clone C4, Chemicon®, from mouse